SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-004230
Filing Date
2022-03-21
Accepted
2022-03-21 16:13:31
Documents
14
Period of Report
2022-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbu-20220321.htm   iXBRL 8-K 51228
2 EX-99.1 crbu-ex99_1.htm EX-99.1 233101
3 GRAPHIC img25401123_0.jpg GRAPHIC 52289
  Complete submission text file 0000950170-22-004230.txt   491642

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20220321.xsd EX-101.SCH 2498
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20220321_lab.xml EX-101.LAB 14160
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20220321_pre.xml EX-101.PRE 10433
8 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20220321_htm.xml XML 4936
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40631 | Film No.: 22755832
SIC: 2836 Biological Products, (No Diagnostic Substances)